25-NSE ·Filed Jul 15, 2026

NUVL

Nuvalent, Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed2mo ago SEC0001354457-26-000693
Notable filing: 25-NSE
Actionable Insight • Neutral

The delisting is a formality following the completed acquisition. Shareholders who have not yet tendered shares should receive the $124.00 cash consideration. No further trading on Nasdaq is expected.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+5d ⚠ clustered
NUVL ▲ 0.00% at T+5d
NEUTRAL call ✗ call lost 0.00% · α vs SPY +0.98% · entry $123.96 → $123.96
Next anchor: T+20d due 7w ago
Entry anchored
Jul 14, 03:59 PM ET
via exchange tick
T+1d
0.00%
call 0.00% · α +0.54%
$123.96
settled 3mo ago
T+5d
0.00%
call 0.00% · α +0.98%
$123.96
settled 2mo ago
T+20d
—
call — · α —
—
due 7w ago
T+60d
—
call — · α —
—
in 6d

Price Chart

Loading chart...

Executive Summary

Nasdaq filed a 25-NSE notification to delist Nuvalent, Inc. shares following the completion of GSK plc's acquisition. The merger closed on July 15, 2026, at $124.00 per share in cash, representing a total equity value of approximately $10.6 billion. This filing is a procedural step finalizing the delisting.

Key Facts

  • Form 25-NSE filed by Nasdaq to remove Nuvalent's Class A Common Stock from listing and registration.
  • Delisting is effective as of July 15, 2026, the same day the GSK acquisition closed.
  • The acquisition was completed at $124.00 per share in cash, with total equity value of approximately $10.6 billion, as reported in the prior 8-K filing.

Financial Impact

Not specified

Risk Factors

  • No residual risk; the deal is closed and the stock is being removed from the exchange.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
35% bullish (23 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
25-NSE Filing (Primary)0001354457-26-000693
Document: 0001354457-26-000693-index-headers.html0001354457-26-000693
Document: 0001354457-26-000693-index.html0001354457-26-000693
Document: 0001354457-26-000693.txt0001354457-26-000693
18 reports for NUVL
Performance horizon
38% Hit rate 3 of 8 directional calls best @ T+60▲ +21.01%Apr 7, 2026
Filters
Rows
Reports for NUVL — sortable, filterable
TypeNow
Jul 27, 2026
9w ago
15-12G
NEUTRAL ★ 3/10
—awaiting T+5——
Jul 15, 2026
11w ago
25-NSE
NEUTRAL ★ 3/10
$123.96 $123.96· 0.00%▲ +0.98%—
Jul 15, 2026
11w ago
8-K
BULLISH ★ 5/10
$123.96 $123.96· 0.00%▲ +0.98%—
Jul 8, 2026
12w ago
Insider Cluster
NEUTRAL ★ 3/10
$123.80 $123.96▲ +0.13%▼ −0.73%—
Jul 6, 2026
12w ago
Insider Cluster
NEUTRAL ★ 3/10
$123.72 $123.90▲ +0.15%▼ −0.34%—
Jun 11, 2026
16w ago
Insider Cluster
NEUTRAL ★ 2/10
$123.25 $123.43▲ +0.15%▼ −0.53%—
Jun 10, 2026
16w ago
Insider Cluster
NEUTRAL ★ 3/10
$123.45 $123.36▼ −0.07%▼ −0.51%—
Jun 9, 2026
16w ago
8-K
BULLISH ★ 8/10
$123.25 $123.35▲ +0.08%▼ −2.33%—
May 7, 2026
21w ago
8-K
NEUTRAL ★ 4/10
$102.40 $105.22▲ +2.75%▲ +1.25%—
Apr 29, 2026
22w ago
Insider Cluster
NEUTRAL ★ 2/10
$99.10 $101.47▲ +2.39%▼ −0.72%—
Showing 10 of 18

US Market Status

Market Open — Closes in 3h 54m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access